FR531M - - Google Patents
Info
- Publication number
- FR531M FR531M FR837316A FR837316A FR531M FR 531 M FR531 M FR 531M FR 837316 A FR837316 A FR 837316A FR 837316 A FR837316 A FR 837316A FR 531 M FR531 M FR 531M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
- 
        - C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
 
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| FR837316A FR531M (enEXAMPLES) | 1958-07-10 | 1960-08-31 | 
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB22148/58A GB851287A (en) | 1958-07-10 | 1958-07-10 | 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof | 
| FR798293A FR1333707A (fr) | 1959-06-23 | 1959-06-23 | Procédé de fabrication du 5-chlorotoluène-2,4-disulfamide et de ses sels alcalins | 
| FR837316A FR531M (enEXAMPLES) | 1958-07-10 | 1960-08-31 | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| FR531M true FR531M (enEXAMPLES) | 1961-05-23 | 
Family
ID=10174686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| FR837316A Active FR531M (enEXAMPLES) | 1958-07-10 | 1960-08-31 | 
Country Status (2)
| Country | Link | 
|---|---|
| FR (1) | FR531M (enEXAMPLES) | 
| GB (1) | GB851287A (enEXAMPLES) | 
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| GB959229A (en) * | 1960-11-18 | 1964-05-27 | Kyowa Hakko Kogyo Company Ltd | Method for producing l-isoleucine by fermentation process | 
| EP0033042B1 (en) * | 1980-01-28 | 1984-08-22 | Merck & Co. Inc. | Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors | 
| IE50901B1 (en) * | 1980-03-04 | 1986-08-06 | Merck & Co Inc | Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure | 
| CN1265788C (zh) | 2000-11-21 | 2006-07-26 | 三共株式会社 | 药物组合物 | 
| EP1545519B1 (en) | 2002-08-19 | 2011-03-23 | Pfizer Inc. | Combination therapy for hyperproliferative diseases | 
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators | 
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors | 
| EP2094643B1 (en) | 2006-12-01 | 2012-02-29 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases | 
| CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 | 
| WO2015012205A1 (ja) | 2013-07-23 | 2015-01-29 | 第一三共株式会社 | 高血圧症の予防又は治療のための医薬 | 
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds | 
| ES3007652T3 (en) | 2019-01-18 | 2025-03-20 | Astrazeneca Ab | 6'-[[(1s,3s)-3-[[5-(difluoromethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-one as pcsk9 inhibitor and methods of use thereof | 
- 
        1958
        - 1958-07-10 GB GB22148/58A patent/GB851287A/en not_active Expired
 
- 
        1960
        - 1960-08-31 FR FR837316A patent/FR531M/fr active Active
 
Also Published As
| Publication number | Publication date | 
|---|---|
| GB851287A (en) | 1960-10-12 |